Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women’s Health Study

International Journal of STD and AIDS

Volumn 26, Issue 12, 2015, Pages 893-902

  Wadhera, Priya ^a,b   Evans, Jennifer L ^a,b   Stein, Ellen ^a,b   Gandhi, Monica ^c   Couture, Marie Claude ^d   Sansothy, Neth ^e   Sichan, Keo ^f   Maher, Lisa ^g   Kaldor, John M ^g   Page, Kimberly ^a,b,h   Kien, Serey Phal ^f   Palefsky, Joel M ^c   Saphonn, Vonthanak ^e   Vun, Mean Chhi ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Global Health RTI International   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SAN FRANCISCO   (United States)

^e National Center for HIV/AIDS   (Cambodia)

^f Cambodian Women's Development Agency   (Cambodia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

attitudes; brief intervention; Cambodia; cervical cancer; female sex workers; HIV; HPV; Human papillomavirus; knowledge; prevention; sexually transmitted infection; vaccine; women

Indexed keywords

AMPHETAMINE; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; CAMBODIA; CONDOM USE; CONDYLOMA ACUMINATUM; DEVELOPING COUNTRY; FEASIBILITY STUDY; FEMALE; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT EDUCATION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROSTITUTION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS; ATTITUDE TO HEALTH; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; PROSPECTIVE STUDY; QUESTIONNAIRE; SEX WORKER; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; CAMBODIA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; SEX WORKERS; SURVEYS AND QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84944567862     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462414563626     Document Type: Article

References (34)

1. D.FormanC.de MartelC.J.Lacey. Global burden of human papillomavirus and related diseases. Vaccine2012; 30: F12–23.
2. K.A.Ault. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol2006; 2006: 40470–40470.
3. L.BruniM.DiazX.Castellsague. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis2010; 202: 1789–1799.
4. J.M.WalboomersM.V.JacobsM.M.Manos. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol1999; 189: 12–19.
5. T.G.HopkinsN.Wood. Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine2013; 31: 1673–1679.
6. X.Castellsague. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol2008; 110: S4–7.
7. M.ArbynX.CastellsagueS.de Sanjose. Worldwide burden of cervical cancer in 2008. Ann Oncol2011; 22: 2675–2686.
8. J.E.TotaM.Chevarie-DavisL.A.Richardson. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med2011; 53: S12–21.
9. C.KietpeerakoolY.PhianmongkholK.Jitvatcharanun. Knowledge, awareness, and attitudes of female sex workers toward HPV infection, cervical cancer, and cervical smears in Thailand. Int J Gynaecol Obstet2009; 107: 216–219.
10. M.C.CoutureK.PageE.S.Stein. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis2012; 12: 166–166.
11. J.M.BrothertonM.FridmanC.L.May. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet2011; 377: 2085–2092.
12. A.C.RodriguezD.SolomonR.Herrero. Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment. Am J Epidemiol2013; 178: 752–760.
13. B.F.de BlasioA.R.NeilsonM.Klemp. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era. J Public Health (Oxf)2012; 34: 539–547.
14. L.L.VillaR.L.CostaC.A.Petta. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol2005; 6: 271–278.
15. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med2007; 356: 1915–1927.
16. M.H.EinsteinM.BaronM.J.Levin. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years. Hum Vaccin2009; 5: 705–719.
17. A.SzarewskiW.A.PoppeS.R.Skinner. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer2012; 131: 106–116.
18. X.CastellsagueN.MunozP.Pitisuttithum. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. Br J Cancer2011; 105: 28–37.
19. D.S.LaMontagneS.BargeN.T.Le. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Org2011; 89: 821–30B.
20. S.PerlmanR.G.WamaiP.A.Bain. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS One2014; 9: e90912–e90912.
21. A.E.StrohlG.MendozaM.S.Ghant. Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women. Am J Obstet Gynecol2015; 212: 65.e1–5.
22. A.Young. HPV vaccine acceptance among women in the Asian Pacific: a review of the literature. Asian Pac J Cancer Prev2011; 11: 641–649.
23. K.PageE.SteinN.Sansothy. Sex work and HIV in Cambodia: trajectories of risk and disease in two cohorts of high-risk young women in Phnom Penh, Cambodia. BMJ Open2013; 3: e003095–e003095.
24. M.C.CoutureN.SansothyV.Sapphon. Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis2011; 38: 33–39.
25. M.C.CoutureJ.L.EvansN.S.Sothy. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend2012; 120: 119–126.
26. B.BrownC.CarcamoM.M.Blas. Peruvian FSWs: understanding HPV and barriers to vaccination. Vaccine2010; 28: 7743–7747.
27. H.DoP.SengJ.Talbot. HPV vaccine knowledge and beliefs among Cambodian American parents and community leaders. Asian Pac J Cancer Prev2009; 10: 339–344.
28. L.MaherP.PhlongJ.Mooney-Somers. Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia. Int J Drug Policy2011; 22: 203–209.
29. B.BrownM.BlasA.Cabral. Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers. Vaccine2012; 30: 2309–2314.
30. B.BrownM.M.BlasO.Heidari. Reported changes in sexual behaviour and human papillomavirus knowledge in Peruvian female sex workers following participation in a human papillomavirus vaccine trial. Int J STD AIDS2013; 24: 531–535.
31. H.C.TurnerI.BaussanoG.P.Garnett. Vaccinating women previously exposed to human papillomavirus: a cost-effectiveness analysis of the bivalent vaccine. PLoS One2013; 8: e75552–e75552.
32. J.A.KahnJ.XuB.G.Kapogiannis. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis2013; 57: 735–744.
33. K.H.SealA.H.KralJ.Lorvick. A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug Alcohol Depend2003; 71: 127–131.
34. L.ToppC.A.DayH.Wand. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med2013; 57: 297–303.